Background: Adjuvant therapy for resected pancreatic adenocarcinoma was given a
category 1 NCCN recommendation in 2000, yet many patients do not receive chemotherapy …

Abstract Background and Methods Racial and socioeconomic disparities in receipt of
adjuvant chemotherapy affect patients with pancreatic cancer. However, differences in …

Purpose: Adjuvant chemotherapy following resection is recommended by clinical practice
guidelines for all patients with pancreatic ductal adenocarcinoma (PDAC). This study aimed …

Objectives Pancreatic cancer (PDAC) with localized stage includes resectable (RPC),
borderline resectable (BRPC), or locally advanced unresectable (LAPC). Standard of care …

Patients affected by pancreatic ductal adenocarcinoma (PDAC) have very poor prognosis,
whereby at a follow-up of 5 years, the mortality rate is very similar to the incidence rate …

Abstract Background This National Cancer Database (NCDB) analysis evaluates the clinical
outcomes of postoperative chemotherapy followed by concurrent chemoradiation (C+ CRT) …

Stereotactic body radiation therapy as an effective treatment for pancreatic cancer patients
with local advanced stage Page 1 Page 1/12 Stereotactic body radiation therapy as an …

Background and Methods: Racial and socioeconomic disparities in receipt ofadjuvant
chemotherapy affect patients with pancreatic cancer. However, differencesin receipt of …

Although cancer mechanisms differ from occurrence and development, some of them have
similar oncogenesis, which leads to similar clinical phenotypes. Most existing genotyping …

Purpose The literature has been conflicting on the superiority of adjuvant chemoradiation
over chemotherapy for node-positive adenocarcinoma of the pancreas following definitive …